Zidan Particle Treatment Of Children Allergic Purpura Health Economics

Objective:this article through to the purple Dan granules treatment the clinical effect of the treatment of allergic purpura in children, and carries on the cost of economic effect evaluation, in the hope from the perspective of health economics, purple Dan particles makes an analysis of the treatment of allergic purpura in children, and to promote more effective and more economical treatment for allergic purpura in children plan provides the basis.Method:the study adopts the method of double-blind, randomized, placebo-controlled, conform to the criteria for the selected144cases of patients, and randomly divided into experimental group and control group,72cases in each group. For the treatment of two groups before and after treatment symptoms integral, number of days for statistical comparison, between the two groups of treatment effect, treatment costs related to the health economics indexes such as cost-effect analysis.Results:in terms of treatment, two groups of drugs are effective. The treatment group cure rate of87.5%, and the control group the cure rate of80.5%; Two groups in terms of symptom treatment, recovery time, the time needed for experimental group obviously less than control group, P<0.05, statistically significant; In hospital cost, outpatient cost and total cost, the experimental group and control group have no significant difference, in terms of hospitalization medical expenses, by the statistical analysis to get P<0.05, suggesting that there are differences between the two groups in terms of medical expenses, experimental group is lower than the control group; Cost-effect analysis of the two groups, experimental group of cost-effectiveness ratio significantly lower than the cost effect than in the control group, the sensitivity analysis shows that research has the reliability.Conclusion:(1) two groups are effect for the treatment of allergic purpura in children, the treatment group can obviously improve the curative effect.(2) two groups of cost in the treatment of children allergic purpura has no obvious difference. Allergic purpura in children by outpatient treatment costs significantly less than the cost of hospitalization. Children with allergic purpura in children in the hospital medical costs purple Dan particles costs significantly lower than the routine treatment.(3) purple Dan granules in treatment of allergic purpura in children has more economic benefits.(4) in terms of safety evaluation, experimental drugs for the treatment of allergic purpura in children with reliability and safety.